Paper36922675
KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.
Jiang W and 12 others. Oncogene, 2023. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma. Papers, record 36922675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36922675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Duct Neoplasms | Major topic |
| Cholangiocarcinoma | Major topic |
| Humans | |
| NF-kappa B | |
| Lymphatic Metastasis | |
| DNA Helicases | |
| Drug Resistance, Neoplasm | |
| RNA Helicases | |
| Poly-ADP-Ribose Binding Proteins | |
| RNA Recognition Motif Proteins | |
| Cell Proliferation | |
| Bile Ducts, Intrahepatic | |
| Cell Line, Tumor | |
| Cell Movement | |
| Tumor Microenvironment | |
| Y-Box-Binding Protein 1 | |
| Oncogene Proteins | |
| Kinesins |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23483479 | NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. | Protein Cell | 2013 | https://conductscience.org/library/papers/23483479 | PubMed |
| 2 | 29123259 | Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29123259 | PubMed |
| 3 | 34352206 | N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. | Mol Cell | 2021 | https://conductscience.org/library/papers/34352206 | PubMed |
| 4 | 33692217 | Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33692217 | PubMed |
| 5 | 34011528 | Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer. | Cancer Immunol Res | 2021 | https://conductscience.org/library/papers/34011528 | PubMed |
| 6 | 30226594 | KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. | Int J Oncol | 2018 | https://conductscience.org/library/papers/30226594 | PubMed |
| 7 | 23209302 | KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression. | J Cell Biol | 2012 | https://conductscience.org/library/papers/23209302 | PubMed |
| 8 | 33380832 | KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33380832 | PubMed |
| 9 | 33431577 | Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma. | Gut | 2022 | https://conductscience.org/library/papers/33431577 | PubMed |
| 10 | 31043744 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. | Nature | 2019 | https://conductscience.org/library/papers/31043744 | PubMed |
| 11 | 28382490 | Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells. | Mol Cell Biochem | 2017 | https://conductscience.org/library/papers/28382490 | PubMed |
| 12 | 34287041 | Orf Virus ORF120 Protein Positively Regulates the NF-κB Pathway by Interacting with G3BP1. | J Virol | 2021 | https://conductscience.org/library/papers/34287041 | PubMed |
| 13 | 34131133 | Structural basis of mechano-chemical coupling by the mitotic kinesin KIF14. | Nat Commun | 2021 | https://conductscience.org/library/papers/34131133 | PubMed |
| 14 | 32690952 | The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. | Nat Immunol | 2020 | https://conductscience.org/library/papers/32690952 | PubMed |
| 15 | 33020468 | G3BP1 controls the senescence-associated secretome and its impact on cancer progression. | Nat Commun | 2020 | https://conductscience.org/library/papers/33020468 | PubMed |
| 16 | 33431813 | BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33431813 | PubMed |
| 17 | 23315968 | Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. | Hepatology | 2013 | https://conductscience.org/library/papers/23315968 | PubMed |
| 18 | 33264573 | Pathogenesis of Cholangiocarcinoma. | Annu Rev Pathol | 2021 | https://conductscience.org/library/papers/33264573 | PubMed |
| 19 | 31113805 | Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31113805 | PubMed |
| 20 | 34413131 | GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. | Gut | 2022 | https://conductscience.org/library/papers/34413131 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698848 | YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42698848 | PubMed |
| 42511704 | Advances in the Molecular Mechanisms of Cholangiocarcinoma: A Comprehensive Review of Biomarkers, Regulatory Pathways and Tumor Microenvironment Reprogramming. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511704 | PubMed |
| 42180604 | Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression. | PeerJ | 2026 | https://conductscience.org/library/papers/42180604 | PubMed |
| 42107065 | G3BP1 Succinylation at K413 is Critical for Cardiac Function by Modulating PI3K-AKT-mTOR Signal Axis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42107065 | PubMed |
| 42036047 | Ubiquitin E3 ligase MYCBP2 targets KIF14 and contributes to acute myeloid leukemia progression. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42036047 | PubMed |
| 41513625 | RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41513625 | PubMed |
| 41511650 | KIF14 in cancer biology: implications for diagnosis and therapy. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/41511650 | PubMed |
| 41507134 | YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41507134 | PubMed |
| 41410179 | Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer. | Cancer Biol Ther | 2025 | https://conductscience.org/library/papers/41410179 | PubMed |
| 41243224 | CD169+ Macrophage-Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41243224 | PubMed |
| 41049446 | PRDX3 Promotes Lymph Node Metastasis in Cervical Cancer by Activating NF-κB Signaling Pathway and Anoikis Resistance. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/41049446 | PubMed |
| 41026307 | Identification of KIF14 as a ferroptosis biomarker for predicting the prognosis and immunotherapy efficacy of bladder cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41026307 | PubMed |
| 40974432 | Kinesin superfamily proteins in ovarian cancer: from molecular mechanisms to clinical applications. | Med Oncol | 2025 | https://conductscience.org/library/papers/40974432 | PubMed |
| 40951482 | Cytoarchitectural changes in the developing cerebellar cortex of the laggard mutant mouse. | Narra J | 2025 | https://conductscience.org/library/papers/40951482 | PubMed |
| 40799245 | YBX1: an RNA/DNA-binding protein that affects disease progression. | Front Oncol | 2025 | https://conductscience.org/library/papers/40799245 | PubMed |
| 40783393 | EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40783393 | PubMed |
| 40707677 | Pan-cancer analysis of UGGT1 in human tumors and experimental validation in breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40707677 | PubMed |
| 40374610 | Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40374610 | PubMed |
| 40292920 | Elevated KIF2C Expression Drives Osteosarcoma Progression by Modulating the Wnt/β-Catenin Signaling Pathway and Contributing to an Immunosuppressive Tumor Microenvironment. | Cancer Med | 2025 | https://conductscience.org/library/papers/40292920 | PubMed |
| 39948570 | TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/39948570 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| G3BP1 | 10146 | PubTator's text mining | https://conductscience.org/library/genes/10146 | NCBI Gene |
| HNF4A | 3172 | PubTator's text mining | https://conductscience.org/library/genes/3172 | NCBI Gene |
| KIF14 | 9928 | PubTator's text mining | https://conductscience.org/library/genes/9928 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| YBX1 | 4904 | PubTator's text mining | https://conductscience.org/library/genes/4904 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36922675
GET https://conductscience.org/api/papers/v1/36922675/references?page=2